I understand what you are saying. But remember thi

I understand what you are saying. But remember this is a public company and the board has a fiduciary duty to the stockholders. When P is finished we will have completed phase 2 for all of our compounds. There is still phase 3. Then FDA approval. Then marketing of the drugs. So this takes 2-3 years before there is any revenue. So what is the no risk present value of cash in hand?
Ideally what I would like to see is a nice buyout plus a stub that gives us say 5% of revenue for 10 years. That could amount to a lot.